BenevolentAI SPAC Presentation Deck
Drug development is failing patients
Expensive & high risk
$160bn+
spent per year
on drug R&D
$2.6bn
in average R&D
and to market
cost per drug
OS- Overall Survival
96%
overall failure
rate in drug
development
The human body is an incredibly
complex information system
(made up of over 37 trillion cells)
Long R&D cycles
10 years
to market
9,000
diseases with no
effective
treatment
The underlying mechanisms of
complex multifactorial diseases
are often misunderstood
Poor efficacy &
high societal cost
Leading drugs
effective on
30-50%
of patients
Approved cancer
drugs have poor
response rates,
with only
7%
showing an OS
advantage
Scientists can't possibly keep up
with exponential growth of
biomedical research and data
(2,314 exabytes of healthcare data
generated last year alone)
Gaining a clear understanding of the underlying molecular mechanisms based on
the totality of available biomedical data is a vital step in the development
of successful and efficacious treatments
Benevolent
8View entire presentation